Stay updated on JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial

Sign up to get notified when there's something new on the JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page now includes a dedicated Locations section with sites in Alabama, Arizona, California, New York, Ohio, Oklahoma, Texas, and Washington, plus an updated revision tag (v3.3.3). The HHS Vulnerability Disclosure link was removed.
    Difference
    0.9%
    Check dated 2025-12-23T22:15:05.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    The revision label in the page footer updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T11:16:37.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Removed the administrative notice banner about a lapse in government funding and NIH operating status. The study details and trial information shown on the page remain the same.
    Difference
    0.4%
    Check dated 2025-11-18T07:01:26.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Results data for the study were posted, including primary and secondary outcomes across ABI, SRS-2, ABC, CGI scales, and related measures. The record dates show Results First Posted on 2025-04-23 and subsequent updates.
    Difference
    0.4%
    Check dated 2025-11-03T20:57:50.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Major change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).
    Difference
    2%
    Check dated 2025-10-06T05:14:28.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Page now shows revision to v3.1.0 and removes several drug-safety-related topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the content, indicating a shift away from those topics while adding a new version.
    Difference
    0.2%
    Check dated 2025-09-29T03:00:24.000Z thumbnail image

Stay in the know with updates to JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial

Enter your email address, and we'll notify you when there's something new on the JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial page.